Xtl Biopharmaceuticals (XTLB) Acquisitions (2012)
Xtl Biopharmaceuticals' Acquisitions was $669,000 in the quarter ended Dec 31, 2015.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Acquisitions (2012) Analysis & Trends
For the year ended Dec 31, 2015, Acquisitions at Xtl Biopharmaceuticals came in at $689,000.
- In earlier years, Acquisitions was -$149,000 in the year ended Dec 31, 2012.
- The figure for the quarter ended Dec 31, 2015 marks the lowest quarterly Acquisitions since the quarter ended Sep 30, 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.45 Bn | 1,115.03 Bn | 19.71 Bn | 8.75 Bn |
| 2 | Johnson & Johnson | 622.49 Bn | 541.02 Bn | 17.26 Bn | -17.24 Bn |
| 3 | AbbVie | 509.47 Bn | 482.58 Bn | 12.70 Bn | - |
| 4 | Merck | 365.43 Bn | 319.80 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.34 Bn | 261.33 Bn | 11.24 Bn | 23.00 Mn |
| 6 | Astrazeneca | 261.32 Bn | 235.01 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.29 Bn | 190.69 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.80 Bn | 167.99 Bn | 6.22 Bn | 11.21 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | - |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
API Access
Xtl Biopharmaceuticals Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();